These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 37843733)
1. Enhanced oral delivery of hesperidin-loaded sulfobutylether-β-cyclodextrin/chitosan nanoparticles for augmenting its hypoglycemic activity: in vitro-in vivo assessment study. Elmoghayer ME; Saleh NM; Abu Hashim II Drug Deliv Transl Res; 2024 Apr; 14(4):895-917. PubMed ID: 37843733 [TBL] [Abstract][Full Text] [Related]
2. Preparation and evaluation of naringenin-loaded sulfobutylether-β-cyclodextrin/chitosan nanoparticles for ocular drug delivery. Zhang P; Liu X; Hu W; Bai Y; Zhang L Carbohydr Polym; 2016 Sep; 149():224-30. PubMed ID: 27261746 [TBL] [Abstract][Full Text] [Related]
3. Sulfobutylether-β-cyclodextrin/chitosan nanoparticles enhance the oral permeability and bioavailability of docetaxel. Wu J; Shen Q; Fang L Drug Dev Ind Pharm; 2013 Jul; 39(7):1010-9. PubMed ID: 22681515 [TBL] [Abstract][Full Text] [Related]
4. Chitosan/Sulfobutylether-β-Cyclodextrin Nanoparticles for Ibrutinib Delivery: A Potential Nanoformulation of Novel Kinase Inhibitor. Zhao L; Tang B; Tang P; Sun Q; Suo Z; Zhang M; Gan N; Yang H; Li H J Pharm Sci; 2020 Feb; 109(2):1136-1144. PubMed ID: 31606544 [TBL] [Abstract][Full Text] [Related]
5. Intranasal delivery of dopamine to the striatum using glycol chitosan/sulfobutylether-β-cyclodextrin based nanoparticles. Di Gioia S; Trapani A; Mandracchia D; De Giglio E; Cometa S; Mangini V; Arnesano F; Belgiovine G; Castellani S; Pace L; Lavecchia MA; Trapani G; Conese M; Puglisi G; Cassano T Eur J Pharm Biopharm; 2015 Aug; 94():180-93. PubMed ID: 26032293 [TBL] [Abstract][Full Text] [Related]
6. Chitosan/sulfobutylether-β-cyclodextrin based nanoparticles coated with thiolated hyaluronic acid for indomethacin ophthalmic delivery. Ricci F; Racaniello GF; Lopedota A; Laquintana V; Arduino I; Lopalco A; Cutrignelli A; Franco M; Sigurdsson HH; Denora N Int J Pharm; 2022 Jun; 622():121905. PubMed ID: 35697201 [TBL] [Abstract][Full Text] [Related]
7. The preparation, characterization, and pharmacokinetic studies of chitosan nanoparticles loaded with paclitaxel/dimethyl-β-cyclodextrin inclusion complexes. Ye YJ; Wang Y; Lou KY; Chen YZ; Chen R; Gao F Int J Nanomedicine; 2015; 10():4309-19. PubMed ID: 26170666 [TBL] [Abstract][Full Text] [Related]
9. Preparation and evaluation of warfarin-β-cyclodextrin loaded chitosan nanoparticles for transdermal delivery. Khalil SK; El-Feky GS; El-Banna ST; Khalil WA Carbohydr Polym; 2012 Oct; 90(3):1244-53. PubMed ID: 22939337 [TBL] [Abstract][Full Text] [Related]
10. A comparative study of chitosan and chitosan/cyclodextrin nanoparticles as potential carriers for the oral delivery of small peptides. Trapani A; Lopedota A; Franco M; Cioffi N; Ieva E; Garcia-Fuentes M; Alonso MJ Eur J Pharm Biopharm; 2010 May; 75(1):26-32. PubMed ID: 20102738 [TBL] [Abstract][Full Text] [Related]
11. Development of a Chitosan-based Nanoparticle Formulation for Ophthalmic Delivery of Honokiol. Deng F; Hu W; Chen H; Tang Y; Zhang L Curr Drug Deliv; 2018; 15(4):594-600. PubMed ID: 28425869 [TBL] [Abstract][Full Text] [Related]
12. Dimethyl-β-cyclodextrin/salazosulfapyridine inclusion complex-loaded chitosan nanoparticles for sustained release. Tang P; Yang H; Tang B; Wu D; Du Q; Xu K; Li H Carbohydr Polym; 2017 Jan; 156():215-222. PubMed ID: 27842816 [TBL] [Abstract][Full Text] [Related]
13. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery. Mahmoud AA; El-Feky GS; Kamel R; Awad GE Int J Pharm; 2011 Jul; 413(1-2):229-36. PubMed ID: 21540097 [TBL] [Abstract][Full Text] [Related]
14. Preparation, Characterization, and Zhang Z; Chen J; Zou L; Tang J; Zheng J; Luo M; Wang G; Liang D; Li Y; Chen B; Yan H; Ding W Int J Nanomedicine; 2022; 17():5287-5302. PubMed ID: 36411767 [TBL] [Abstract][Full Text] [Related]
15. Cyclodextrin/chitosan nanoparticles for oral ovalbumin delivery: Preparation, characterization and intestinal mucosal immunity in mice. He M; Zhong C; Hu H; Jin Y; Chen Y; Lou K; Gao F Asian J Pharm Sci; 2019 Mar; 14(2):193-203. PubMed ID: 32104451 [TBL] [Abstract][Full Text] [Related]
16. pH and temperature stability of (-)-epigallocatechin-3-gallate-β-cyclodextrin inclusion complex-loaded chitosan nanoparticles. Liu F; Majeed H; Antoniou J; Li Y; Ma Y; Yokoyama W; Ma J; Zhong F Carbohydr Polym; 2016 Sep; 149():340-7. PubMed ID: 27261758 [TBL] [Abstract][Full Text] [Related]
17. Chitosan-graft-β-cyclodextrin nanoparticles as a carrier for controlled drug release. Yuan Z; Ye Y; Gao F; Yuan H; Lan M; Lou K; Wang W Int J Pharm; 2013 Mar; 446(1-2):191-8. PubMed ID: 23422276 [TBL] [Abstract][Full Text] [Related]
18. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment. Bagre AP; Jain K; Jain NK Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363 [TBL] [Abstract][Full Text] [Related]
19. Sulfobutylether-β-cyclodextrin: A functional biopolymer for drug delivery applications. Pardeshi CV; Kothawade RV; Markad AR; Pardeshi SR; Kulkarni AD; Chaudhari PJ; Longhi MR; Dhas N; Naik JB; Surana SJ; García MC Carbohydr Polym; 2023 Feb; 301(Pt B):120347. PubMed ID: 36446486 [TBL] [Abstract][Full Text] [Related]
20. Sulfobutylether-β-cyclodextrin/chitosan nano- and microparticles and their physicochemical characteristics. Fülöp Z; Saokham P; Loftsson T Int J Pharm; 2014 Sep; 472(1-2):282-7. PubMed ID: 24971695 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]